A Study of CDX-622 in Participants With Mild to Moderate Asthma

NCT07330778 · clinicaltrials.gov ↗
PHASE1
Phase
RECRUITING
Status
12
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Celldex Therapeutics